1 |
Basu D, Kulkarni R. Overview of blood components and their preparation[J]. Indian J Anaesth, 2014, 58 (5): 529-537.
|
2 |
Watanabe M, Murata S, Hashimoto I, et al. Platelets contribute to the reduction of liver fibrosis in mice[J]. J Gastroenterol Hepatol, 2009, 24 (1): 78-89.
|
3 |
Kodama T, Takehara T, Hikita H, et al. Thromboyto-penia exacerbates cholestasis-induced liver fibrosis in mice[J]. Gastroenterology, 2010, 138 (7): 2487-2498, 2498.e1-e7.
|
4 |
Ikeda N, Murata S, Maruyama T, et al. Platelet-deriv-ed adenosine 5'-triphosphate suppresses activation of human hepatic stellate cell: in vitro study [J]. Hepatol Res, 2012, 42 (1): 91-102.
URL
|
5 |
Lisman T, Porte RJ. The role of platelets in liver in-flammation and regeneration[J]. Semin Thromb Hemost, 2010, 36 (2): 170-174.
|
6 |
Bhogal RH, Weston CJ, Curbishley SM, et al. Activation of CD40 with platelet derived CD154 promotes reactive oxygen species dependent death of human hepatocytes during hypoxia and reoxygenation[J]. PLoS One, 2012, 7 (1): e30867.
|
7 |
章渭方,方君俊,王国彬,等. 重组人血小板生成素治疗脓毒症相关血小板减少症患者的临床研究[J/CD]. 中华危重症医学杂志(电子版),2016,9(5):300-308.
URL
|
8 |
Walasek MA, van Os R, de Haan G. Hematopoietic stem cell expansion: challenges and opportunities[J]. Ann N Y Acad Sci, 2012, 6 (6): 138-150.
|
9 |
方俊君,章渭方. 脓毒症早期集束化治疗的研究进展[J/CD]. 中华危重症医学杂志(电子版),2014,7(6):374-376.
|
10 |
Kuter DJ, Begley CG. Recombinant human thrombo-poietin: basic biology and evaluation of clinical studies[J]. Blood, 2002, 100 (10): 3457-3569.
|
11 |
Guo F, Wang X, Huan J, et al. Association of platelet counts decline and mortality in severely burnt patients[J]. J Crit Care, 2012, 27 (5): 529e1-e7.
|
12 |
Birbrair A, Frenette PS. Niche heterogeneity in the bone marrow[J]. Ann N Y Acad Sci, 2016, 1370 (1): 82-96.
|
13 |
Nakamura-Ishizu A, Suda T. Hematopoietic stem cell niche: an interplay among a repertoire of multiple functional niches[J]. Biochim Biophys Acta, 2013, 1830 (2): 2404-2409
|
14 |
Strassel C, Brouard N, Mallo L, et al. Aryl hydrocarbon receptor-dependent enrichment of a megakaryocytic precursor with a high potential to produce proplatelets[J]. Blood, 2016, 127 (18): 2231-2240.
|
15 |
Brouard N, Jost C, Matthias N, et al. A unique microenvironment in the developing liver supports the expansion of megakaryocyte progenitors[J]. Blood Adv, 2017, 1 (21): 1854-1866.
|
16 |
Aihara A, Koike T, Abe N, et al. Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells[J]. Blood Adv, 2017, 1 (7): 468-476.
|
17 |
Sim X, Jarocha D, Hayes V, et al. Identifying and enriching platelet-producing human stem cell-derived megakaryocytes using factor V uptake[J]. Blood, 2017, 130 (2): 192-204.
|
18 |
Nakano Y, Kondo T, Matsuo R, et al. Platelet dynamics in the early phase of postischemic liver in vivo[J]. J Surg Res, 2008, 149 (2): 192-198.
|
19 |
Matsuo R, Ohkohchi N, Murata S, et al. Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro[J]. J Surg Res, 2008, 145 (2): 279-286.
|
20 |
Larkin CM, Santos-Martinez MJ, Ryan T, et al. Sepsis-associated thrombocytopenia[J]. Thromb Res, 2016 (141): 11-16.
|